Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06146517 · ClinicalTrials.gov registry record · NA

A Single-Arm, Virtual Clinical Trial to Evaluate the Effects of a Sleep Supporting Beverage and Two Coffee Substitute Products

A NA study of Anxiety and Sleep, sponsored by Clevr Blends.

Completed
Registry status
NA
Development phase
32
Enrollment target
1
Study location

NCT06146517 is a NA study of Anxiety and Sleep that has completed, run by Clevr Blends. The registered enrollment target is 32 participants, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06146517, a NA study of Anxiety and Sleep, has completed, sponsored by Clevr Blends.

COMPLETED
Registry status
NA
Development phase
32 participants
Enrollment target
1
Study location

Study Summary

This is a virtual, single-arm clinical trial that will last 12 weeks. Participants will trial three different products, each for 4 weeks. Participants will trial Clevr Blends Sleeptime during weeks 1-4, Clevr Matcha for weeks 5-8, and Clevr Blends Chai for weeks 9-12. Participants will complete questionnaires at Baseline and Week 2, 4, 6, 8, 10, and 12. In addition to data will be collected from participants' sleep tracking devices at Baseline, Week 2, and Week 4.

Interventions

  • OTHER Clevr Sleeptime
  • OTHER Clevr Matcha
  • OTHER Clevr Chai

Study Locations (1)

California

  • Citruslabs - Santa Monica

Trial Details

FieldValue
Enrollment Target 32 participants
Start Date 2023-08-31
Est. Completion 2024-01-22
Phase NA

Sponsor

Clevr Blends

1 total trials

What the Registry Record Tells You About NCT06146517

The ClinicalTrials.gov registry entry for NCT06146517 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (93% lower). The listed sponsor is Clevr Blends, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Anxiety appearing as the primary indexed condition, and to 3 interventions - of which Clevr Sleeptime is the first listed.

NCT06146517 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT06146517 about?

NCT06146517 is a clinical study titled "A Single-Arm, Virtual Clinical Trial to Evaluate the Effects of a Sleep Supporting Beverage and Two Coffee Substitute Products". This is a virtual, single-arm clinical trial that will last 12 weeks. Participants will trial three different products, each for 4 weeks. Participants will trial Clevr Blends Sleeptime during weeks 1-4, Clevr Matcha for weeks 5-8, and Clevr Blends Chai for weeks 9-12. Participants will complete ques...

What is the current status of trial NCT06146517?

This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2023-08-31. Estimated completion is 2024-01-22.

What conditions does trial NCT06146517 study?

This clinical trial studies the following conditions: Anxiety, Sleep, Mood, Caffeine Withdrawal, Productivity.

What interventions are being tested in trial NCT06146517?

The interventions under investigation include: Clevr Sleeptime (OTHER), Clevr Matcha (OTHER), Clevr Chai (OTHER).

Who is sponsoring clinical trial NCT06146517?

This trial is sponsored by Clevr Blends, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06146517 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anxiety

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.